MUMBAI, March 7, 2016 /PRNewswire/ --
CPhI Conferences, a division of UBM India which hosts a number of successful pharmaceutical conferences, has announced the 5th Annual Pharma IPR Conference slated for 9th - 11th March 2016 at The Westin in Mumbai.
(Logo: http://photos.prnewswire.com/prnh/20160307/10141644 )
(Logo: http://photos.prnewswire.com/prnh/20130226/599595-c )
The conference will focus on the understanding of the patent and Intellectual Property (IP) laws of over 15 countries such as USA, Europe, Brazil, Africa, India, Australia and Japan amongst others and its implications on the Indian Pharma industry. This gathering will also help the industry to generate exposure and enter newer and uncharted markets.
The gathering, which promises to be the biggest IP platform, will see the presence of intellectual minds that will meet and discuss the new facets, key current issues and way forward for this industry. It will also have case study discussions on Pharma and Bio-Pharma patents and panel discussions by dignitaries on IP strategies for Complex Generics in the US and 'Moving Indian Pharma Industry into Innovation' which will be followed by Q & A sessions.
In this year's edition, the conference will also introduce an exclusive Moot Court Session, a simulated court room experience, wherein patent attorneys will be discussing the litigation issues in detail plus the nuances of actual proceedings. The attendees will be given an opportunity to ask most critical questions regarding the cases and achieve in-depth understanding of legal challenges in IPR.
Eminent industry speakers like Taranpreet Singh Lamba, Vice President - Intellectual Property Management, Glenmark Pharmaceuticals; Alpesh Pathak - Global IP Head, Intas Pharmaceuticals Ltd.; Leena Menghaney - Regional Head - South Asia, MSF - Access Campaign; Mandar Kodgule - Senior Vice President, Global IP & Corporate Strategy, Wockhardt Ltd.; Mahalaxmi Andheria - Vice President - Intellectual Property Cell, Panacea Biotec Ltd.; Dennies Varughese, Pharm.D. Director, Sterne Kessler Goldstein & Fox; Aaron F Barkoff - Shareholder, Mcandrews; Jonathan Atkinson - Partner, HGF; Paul A Braier, Ph.D. Esq - Partner, Greenblum & Bernstein, P.L.C., USA amongst others will be part of the three-day conference.
http://www.pharmaipr-india.com/
About UBM India:
UBM India is India's leading exhibition organizer that provides the industry with platforms that bring together buyers and sellers from around the world, through a portfolio of exhibitions, content led conferences and seminars. UBM India hosts over 25 large scale exhibitions and 40 conferences across the country every year; thereby enabling trade across multiple industry verticals. A UBM Asia Company, UBM India has offices across Mumbai, New Delhi, Bangalore and Chennai. UBM Asia is owned by UBM plc which is listed on the London Stock Exchange. UBM Asia is the leading exhibition organizer in Asia and the biggest commercial organizer in mainland China, India and Malaysia.
For more information visit: ubmindia.in
Media Contact:
Mili Lalwani
mili.lalwani@ubm.com
+91-22-61727000
UBM India Pvt. Ltd.
